What's new

Human medicines European public assessment report (EPAR): Yselty, linzagolix choline, Date of authorisation: 14/06/2022, Revision: 5, Status: Authorised

Human medicines European public assessment report (EPAR): Yselty, linzagolix choline, Date of authorisation: 14/06/2022, Revision: 5, Status: Authorised

Mar 12, 2025 - 16:47
 0
Human medicines European public assessment report (EPAR): Yselty, linzagolix choline, Date of authorisation: 14/06/2022, Revision: 5, Status: Authorised
Human medicines European public assessment report (EPAR): Yselty, linzagolix choline, Date of authorisation: 14/06/2022, Revision: 5, Status: Authorised
Read More

Tags:

Previous Article

Human medicines European public assessment report (EPAR): Sugammadex Mylan, suga...

Next Article

What women want from food and beverages

Related Posts

DARWIN EU Advisory Board meeting: 3 May 2024, Online, European Medicines Agency, Amsterdam, the Netherlands, from 3 May 2024, 13:00 (CEST) to 3 May 2024, 14:30 (CEST)

DARWIN EU Advisory Board meeting: 3 May 2024, Online, E...

Feb 20, 2025  0

Human medicines European public assessment report (EPAR): Ebvallo, tabelecleucel, Date of authorisation: 16/12/2022, Revision: 6, Status: Authorised

Human medicines European public assessment report (EPAR...

Feb 18, 2025  0

Herbal medicinal product: Eucalypti aetheroleum, Eucalyptus globulus Labill.,Eucalyptus polybractea  R.T. Baker,Eucalyptus smithii  R.T. Baker, F: Assessment finalised

Herbal medicinal product: Eucalypti aetheroleum, Eucaly...

Feb 28, 2025  0